CEO Robert Ford told investors the company had considered raising its earnings forecast for 2025, but decided to maintain it in light of the new tariffs.

Attorneys say the FDA is unlikely to challenge the court’s decision, though Congress could still look to modernize lab test ...

CFO Joe Wolk, who revealed the figure Tuesday morning on CNBC, told investors the charge was primarily in the healthcare ...